US Patent 9303029 Substituted quinoxalines as FGFR kinase inhibitors
Patent 9303029 was granted and assigned to Astex Therapeutics Limited on April, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 26, 2012
0
Date of Patent
April 5, 2016
0
Patent Applicant
Patent Application Number
14354636
0
Patent Citations Received
Patent Inventor Names
Christopher William Murray
0
Steven John Woodhead
0
Valerio Berdini
0
Virginie Sophie Poncelet
0
Gilbert Ebai Besong
0
Gordon Saxty
0
Lieven Meerpoel
0
Olivier Alexis Georges Querolle
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9303029 Substituted quinoxalines as FGFR kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.